Transcript
Dr. Ganesh Taylor (0:00)
Hello and welcome to Intelligence Squared, where great minds meet. I'm Dr. Ganesh Taylor, a fellow and group leader at the University of Edinburgh. This episode is part of the Prostate Cancer Perspectives series brought to you in collaboration with Bayer. Today we'll be tackling the future of prostate cancer care, reflecting on what prostate cancer care means in practice and how the way we think about the disease is shifting and must continue to shift, is the years ahead. Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide. Each year, around 1.5 million men are diagnosed and nearly 400,000 lose their lives to the disease and these numbers are rising. Diagnoses are in fact projected to double from 1.4 million annually in 2020 to 2.9 million by 2040. In the US the proportion of men diagnosed with advanced stage prostate cancer has doubled in recent years. This is due to the increasing incidence of advanced stage disease and changing guidelines regarding the Prostate Specific Antigen screening test implemented in the US in 2012. In England, nearly one in five men are diagnosed only once the cancer has already spread. Scientific advances have transformed treatment in recent years, yet the lived reality of prostate cancer still extends far beyond the clinic. The disease reshapes daily life and may leave men and their families grappling with difficult choices about how to manage the disease. Advanced prostate cancer is often associated with long term challenges leading to greater levels of unmet needs in supportive care. In today's discussion, we'll follow the prostate cancer journey from diagnosis through to long term management, asking how patients and clinicians can share decisions and foster open communication to support personalised disease management. We'll also consider what it means to navigate life with prostate cancer and the importance of holistic care to support life, not just disease. Looking ahead, we'll also hear perspectives on how we can rethink what truly patient centered care could mean in the years to come. To do so, I've brought together three voices at the center of this story. Courtney Bugler is CEO and President of US prostate cancer advocacy group Zero Prostate Cancer, spearheading the organization's strategy, organizational growth, fundraising and advocacy initiatives. Throughout her career she has been a relentless champion for human equity, public health, communications and patient centered care. Her passion to be at the forefront of the fight against prostate cancer is also deeply personal. As a caregiver to her father who is living with the disease, Dr. Pedro Barata is a board certified Fellowship trained medical oncologist at the University Hospital Sideman's Cancer center and an Associate professor of Medicine at Case Western Reserve University School of Medicine. He's also a renowned clinical trialist and a prolific author and co author, serving as the Prostate Cancer Section Editor for the Oncologist Journal, a member of the editorial team of the Translational Oncology Journal, and Deputy Editor for the American Society of Clinical Oncology Education Book Tony Collier is a semi retired accountant and an ambassador, awareness speaker and fundraiser for UK charity Prostate Cancer UK. He was diagnosed with advanced prostate cancer in 2017 after noticing a pain in his groin while training for an ultramarathon. He is now on a mission to raise awareness of testing and the importance of physical exercise to support others who have been diagnosed. He also serves as Trustee and Vice Chair of another patient led UK charity, Tackle Prostate Cancer. Thank you to Courtney, Dr. Berata and Tony for joining us today. Tony, can you take us back to that moment in 2017 when you received your diagnosis and your perspective today? How did it impact your day to day life both emotionally and physically?
